Is DRUG or DWTX more undervalued in 2026?

CirclFi compares Bright Minds Biosciences Inc. (DRUG) and Dogwood Therapeutics, Inc. (DWTX) using 13 institutional-grade valuation models. DRUG has a Quality of Company score of 4.4/10 while DWTX scores 3.6/10.

Which is a better buy — DRUG or DWTX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do DRUG and DWTX valuations compare?

DRUG at $89.49 and DWTX at $1.67 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

DRUG vs DWTX Valuation Comparison 2026 — Intrinsic Value Analysis

DRUG

Biotechnology

Bright Minds Biosciences Inc.

Quality

4.4

out of 10

Value Trap

SAFE

Price

$89.49

Last close

Models

8/13

Active

DWTX

Biotechnology

Dogwood Therapeutics, Inc.

Quality

3.6

out of 10

Value Trap

LOW

Price

$1.67

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	DRUG Fair Value	DRUG Upside	DWTX Fair Value	DWTX Upside
Bayesian DCF	Intrinsic	$24.06	-73.1%	$0.56	-61.9%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	—	—	$0.05	-96.7%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$85.26	-4.7%	$0.55	-69.3%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for DRUG vs DWTX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

DRUG vs DWTX — Which Stock Is More Undervalued?

DRUG scores higher with a 4.4/10 quality rating vs DWTX's 3.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Bright Minds Biosciences Inc. (DRUG) and Dogwood Therapeutics, Inc. (DWTX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

DRUG currently trades at $89.49 with a QOC of 4.4/10, while DWTX trades at $1.67 with a QOC of 3.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).